ABCA1 and hyperlipidemia: This mechanistic insight underscores the importance of considering both lipid-related genetic factors, such as ABCA1 polymorphisms, and systemic lipid status, such as hyperlipidemia, when assessing the risk and progression of neurodegenerative diseases and atherosclerotic complications [15,16,17,18,19,20].